Axa S.A. Cabaletta Bio, Inc. Transaction History

Axa S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.04 - $2.48 $456 - $1,088	439 Added 0.16%	270,516 $411,000
Q1 2025 May 15, 2025	SELL	$1.39 - $2.74 $480 - $948	-346 Reduced 0.13%	270,077 $375,000
Q4 2024 Feb 14, 2025	SELL	$1.87 - $4.91 $805 - $2,116	-431 Reduced 0.16%	270,423 $594,000
Q3 2024 Nov 14, 2024	BUY	$3.94 - $8.24 $299 - $626	76 Added 0.03%	270,854 $1.28 Million
Q2 2024 Feb 25, 2025	BUY	$7.22 - $18.82 $2,563 - $6,681	355 Added 0.13%	270,778 $2.03 Million

Q2 2024 Aug 14, 2024	BUY	$7.22 - $18.82 $668,687 - $1.74 Million	92,616 Added 51.98%	270,778 $2.03 Million
Q1 2024 May 15, 2024	BUY	$16.79 - $25.38 $2.99 Million - $4.52 Million	178,162 New	178,162 $3.04 Million

72.8M

1.1M

14.9K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $67M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.